Zimmer Biomet Holdings Inc ZBH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Zimmer Biomet's Hip Replacement Device Increases Risk of Thigh Fracture, FDA Says
-
Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations
-
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024
-
Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences
-
Zimmer Biomet Announces Second Quarter 2024 Financial Results
-
Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems, Inc.
-
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results
-
Medical-device makers' stocks jump as procedures keep going strong
Trading Information
- Previous Close Price
- $98.00
- Day Range
- $113.00–113.00
- 52-Week Range
- $97.00–113.00
- Bid/Ask
- $83.00 / $117.00
- Market Cap
- $23.22 Bil
- Volume/Avg
- 1 / 1
Key Statistics
- Price/Earnings (Normalized)
- 15.75
- Price/Sales
- 3.39
- Dividend Yield (Trailing)
- 0.77%
- Dividend Yield (Forward)
- 0.75%
- Total Yield
- 3.75%
Company Profile
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Value
- Total Number of Employees
- 18,000
- Website
- https://www.zimmerbiomet.com
Competitors
Valuation
Metric
|
ZBH
|
JNJ
|
SYK
|
---|---|---|---|
Price/Earnings (Normalized) | 15.75 | 15.29 | 31.28 |
Price/Book Value | 1.95 | 5.39 | 6.77 |
Price/Sales | 3.39 | 4.55 | 6.31 |
Price/Cash Flow | 13.01 | 17.30 | 29.81 |
Price/Earnings
ZBH
JNJ
SYK
Financial Strength
Metric
|
ZBH
|
JNJ
|
SYK
|
---|---|---|---|
Quick Ratio | 0.51 | 0.77 | 0.81 |
Current Ratio | 1.29 | 1.07 | 1.68 |
Interest Coverage | 6.02 | 24.45 | 12.28 |
Quick Ratio
ZBH
JNJ
SYK
Profitability
Metric
|
ZBH
|
JNJ
|
SYK
|
---|---|---|---|
Return on Assets (Normalized) | 6.34% | 13.17% | 11.13% |
Return on Equity (Normalized) | 10.81% | 32.42% | 23.26% |
Return on Invested Capital (Normalized) | 8.45% | 20.93% | 14.77% |
Return on Assets
ZBH
JNJ
SYK
Medical Devices Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Abbott Laboratories
ABT
| Kfxqwhqd | Qydltr | $196.0 Bil | |||
Stryker Corp
SYK
| Dhcvbygjp | Lmvm | $133.8 Bil | |||
Boston Scientific Corp
BSX
| Qdmhkhvls | Rpzssm | $124.5 Bil | |||
Medtronic PLC
MDT
| Gbcthgz | Ddvty | $113.2 Bil | |||
Edwards Lifesciences Corp
EW
| Dccnyskrlg | Vrgkndl | $39.5 Bil | |||
Koninklijke Philips NV ADR
PHG
| Dmqjn | Hvpqj | $30.2 Bil | |||
DexCom Inc
DXCM
| Cbtglkclby | Cmcnw | $27.3 Bil | |||
Steris PLC
STE
| Kfqtwtzr | Bswrztb | $22.8 Bil | |||
Zimmer Biomet Holdings Inc
ZBH
| Zxbjqztl | Ryz | $21.3 Bil | |||
Insulet Corp
PODD
| Lgcnffqmqb | Lgmcv | $16.1 Bil |